Some studies have indicated that PD patients with LRRK2 gene mutations have a higher risk of developing colorectal cancer (Wang et al., 2024), which contradicts research that does not take PD subtypes into account (Fang et al., 2021). The gene discussed is LRRK2; the disease is colorectal cancer.